Michael G. Goldstein

External validity: we need to do more (2006)

Glasgow, Russell E., Green, Lawrence W., Klesges, Lisa M., Abrams, David B., Fisher, Edwin B., Goldstein, Michael G., ...

The article discusses the implications of two health research trends for improving the design, review and reporting of research and evaluation studies in the U.S. The first trend is the gap between...

Translating what we have learned into practice. Principles and hypotheses for interventions addressing multiple behaviors in primary care (2004)

Glasgow, Russell E., Goldstein, Michael G., Ockene, Judith K., Pronk, Nicolaas P.

BACKGROUND: The evidence base regarding what works in practice for helping patients change multiple risk behaviors is less developed than is the more basic literature on behavior change. Still, there...

Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment (2002)

Niaura, Raymond, Spring, Bonnie, Borrelli, Belinda, Hedeker, Donald, Goldstein, Michael G., Keuthen, Nancy J., ...

The authors evaluated the efficacy of fluoxetine hydrochloride (Prozac; Eli Lilly and Company, Indianapolis, IN) as an adjunct to behavioral treatment for smoking cessation. Sixteen sites randomized...

Guideline Development and Use (2000)

Michael C. Fiore, Md (panel Chair, William C. Bailey, Stuart J. Cohen, Sally Faith Dorfman, Michael G. Goldstein, ...

Clinical Practice Guideline, is the result of an extraordinary partnership among Federal Government and nonprofit organizations comprised of the Agency for

Considerations for extending the transtheoretical model of behavior change to screening mammography (1996)

Rakowski, William, Dube, Catherine A., Goldstein, Michael G.

This paper reviews issues that have arisen in the process of extending the Transtheoretical Model of behavior change (TTM) from smoking cessation to screening mammography. Conceptual and empirical...